NK1 and substance P antagonist agents have also been utilized to improve outcomes after traumatic brain injury, particularly when administered in the early postoperative phase [35–37] and found to decrease postinjury cerebral edema by increasing the blood-brain barrier [38]. This evidence concerns the gene TAC1 and brain injury.